![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/05/16/2883210/0/en/South-Rampart-Pharma-Publishes-SRP-001-s-Unique-Pain-Relief-Mechanism-and-Phase-1-Trial-Results-in-Scientific-Reports.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-to-present-at-biotech-showcase-2024-302024127.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-successfully-completes-phase-1-study-and-expands-phase-2-plans-to-include-neuropathic-and-acute-pain-trials-302024129.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-expands-global-patent-portfolio-with-eu-approval-for-fda-fast-tracked-srp-001-for-pain-301973561.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-receives-us-fda-fast-track-designation-for-srp-001-for-acute-pain-301954306.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-to-participate-in-upcoming-investor-events-301950330.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-awarded-second-nih-grant-for-commercialization-readiness-pilot-program-301935198.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-announces-first-patient-enrolled-in-multiple-ascending-dose-portion-of-ongoing-phase-1-clinical-trial-301906230.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-further-expands-patent-portfolio-for-srp-001-with-composition-of-matter-patent-in-china-301869284.html
https://www.prnewswire.com/news-releases/south-rampart-pharma-to-present-at-2023-bio-ceo--investor-conference-301733524.html